A Prospective Phase III Parallel, randomised controlled trial using double-bolus recombinant staphylokinase (THR-100) vs streptokinase in patients with acute myocardial infarction.
Phase of Trial: Phase III
Latest Information Update: 24 Aug 2016
At a glance
- Drugs THR 100 (Primary) ; Streptokinase
- Indications Myocardial infarction
- Focus Registrational; Therapeutic Use
- 26 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Mar 2011 Additional location identified (USA) and actual initiation date (Oct 2010) added as reported by ClinicalTrials.gov.
- 01 Mar 2011 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health; NCT01305226).